Governed REIT Monitoring Solutions in New York (2026): A Comparison Framework for Senior Housing Portfolios

Credibility does not require perfection. It requires making limitations visible, distinguishing design from demonstrated capability, and stating what evidence would change the assessment.

Last verified October 22, 2026 · the single status date used on every page

Component status describes controlled-environment progress only. The Operator-Controlled Operating Record as a whole is designed and not yet implemented in any community as of October 22, 2026; no operator-production deployment or measured operator outcome is claimed.

Current capability and deployment boundary

Operators may retain existing systems, or select future SeniorCRE system-of-record functions after their required gates clear. Neither replacement nor immediate production availability is implied.

Designed

The Operator-Controlled Operating Record is designed and not yet implemented in any community. Authority rules, reconciliation, and field-level lineage are design intent; synthetic examples do not establish working governance. Request implemented source authority, reconciliation and lineage, followed by operator-owned acceptance. Medication administration/eMAR remains not built.

Built

Clinical record surfaces are built; a built surface is not an accepted clinical system or a built operating record. Provisioning controls have been exercised repeatedly in controlled SeniorCRE conditions, including the operator onboarding wizard. Not yet performed for an operator in production; no standard duration is published. Inspect the exact function and executable artifact; require function-specific safety, security and workflow gates before reliance. Request the controlled test record, data classification and limitations. Synthetic/de-identified tests are not operator acceptance or a live named-vendor connector.

Operator deployment

No workflow has been accepted end to end by a named operator owner against operator data. Require the named operator owner, scope, acceptance date and the accepted workflow record.

Production evidence

No operator-production deployment, 10+ community rollout or measured production result is established. Require named operator consent, scope, acceptance date, baseline and measured production evidence before treating a result as proven.

Clinical scope and explicit exclusions

Clinical record surfaces are built; medication administration and eMAR remain roadmap — not built, excluded from Road 2 starting scope and unavailable for production today. The future native clinical configuration requires function-specific build completion, clinical-safety review and clinical sign-off, end-to-end workflow validation, data readiness, operator acceptance before production entry. No community runs SeniorCRE as its clinical system of record.

No operator-production deployment, live named connector, measured portfolio rollout or standard go-live duration is claimed. Replacement of a fixed number of systems within hours is not an available offer or a measured result. Medication administration/eMAR and third-party write-back are excluded from starting scope. Synthetic examples, architecture documents and controlled tests are not operator acceptance.